{"first_name":"Markus","last_name":"Warmuth","permalink":"markus-warmuth","crunchbase_url":"http://www.crunchbase.com/person/markus-warmuth","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Wed Nov 02 05:24:15 UTC 2011","updated_at":"Wed Nov 02 05:40:34 UTC 2011","overview":"<p>Dr. Markus Warmuth joined H3 Biomedicine as Chief Scientific Officer in August 2011 and became President and Chief Executive Officer on October 1, 2011. Markus brings significant experience in cancer biology, drug discovery and clinical oncology to H3. During his career as a pharmaceutical industry research executive, he has successfully built and shaped oncology research groups and portfolios.</p>\n\n<p>Prior to joining H3, Markus was Head of Oncology Drug Discovery for the Novartis Institute for Biomedical Research (NIBR), Cambridge (U.S.) Site. There, he oversaw a significant part of NIBRâ€™s global oncology drug discovery portfolio from target discovery to clinical development.</p>","image":null,"degrees":[],"relationships":[{"is_past":false,"title":"President and Chief Executive Officer","firm":{"name":"H3 Biomedicine","permalink":"h3-biomedicine","type_of_entity":"company","image":{"available_sizes":[[[150,76],"assets/images/resized/0016/0497/160497v1-max-150x150.jpg"],[[250,126],"assets/images/resized/0016/0497/160497v1-max-250x250.jpg"],[[264,134],"assets/images/resized/0016/0497/160497v1-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}